Skip to main content
Advertisement
Advertisement

GH

GH logo

Guardant Health, Inc. Common Stock

167.47
USD
Sponsored
+1.91
+1.15%
Oct 09, 16:00 UTC -4
Closed
exchange

After-Market

167.75

+0.28
+0.17%

GH Earnings Reports

Positive Surprise Ratio

GH beat 14 of 32 last estimates.

44%

Next Report

Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$360.71M
/
-$0.31
Implied change from Q2 26 (Revenue/ EPS)
+4.56%
/
-26.19%
Implied change from Q3 25 (Revenue/ EPS)
+36.02%
/
-58.11%

Guardant Health, Inc. Common Stock earnings per share and revenue

On Jul 30, 2026, GH reported earnings of -0.42 USD per share (EPS) for Q2 26, missing the estimate of -0.41 USD, resulting in a -0.02% surprise. Revenue reached 344.98 million, compared to an expected 323.65 million, with a 6.59% difference. The market reacted with a +6.33% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 23 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 360.71 million USD, implying an decrease of -26.19% EPS, and increase of 4.56% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
logo
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
FAQ
For Q2 2026, Guardant Health, Inc. Common Stock reported EPS of -$0.42, missing estimates by -0.02%, and revenue of $344.98M, 6.59% above expectations.
The stock price moved up 6.33%, changed from $152.35 before the earnings release to $161.99 the day after.
The next earning report is scheduled for Oct 29, 2026.
Based on 23 analysts, Guardant Health, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of $360.71M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement